Ncardia Acquires STAR-CRISPR Technology for Advanced Gene Editing of iPSCs
Unveiling Ncardia's Path to Innovation and Growth
The Urgent Need for Reliable Cell Models in ALS Research
Ncardia's Remarkable Journey in 2023
Ncardia Welcomes Divisional CEO, Dr. Jeroen de Groot
Development of next generation of high-tech equipment for cell culture applications.